Improving outcome prediction of systemic sclerosis from isolated Raynaud's phenomenon: role of autoantibodies and nail-fold capillaroscopy
- PMID: 20100796
- DOI: 10.1093/rheumatology/kep447
Improving outcome prediction of systemic sclerosis from isolated Raynaud's phenomenon: role of autoantibodies and nail-fold capillaroscopy
Abstract
Objective: A simple weighted prognostic algorithm, based on capillaroscopy and autoantibodies, is developed to classify patients at different risk of transition from isolated RP to SSc within 5 years from the screening visit.
Methods: Two hundred and eighty-eight of 768 patients with isolated RP who underwent capillaroscopy were recruited. The prognostic contributions of capillaroscopic findings (giant loops, haemorrhages and the number of capillaries) and SSc-associated autoantibodies (ACAs, anti-topo I and ANAs) were assessed in a semi-parametric regression models suitable for competing risks. A prognostic index was built by a bagging technique. A structured tree approach was used to extract simple classificatory rules that can be directly interpreted.
Results: Thirty-four transitions from isolated RP to SSc and 42 to other CTDs were observed. All of the chosen variables had a substantial prognostic impact. A complex non-linear prognostic pattern was observed for capillaries, with the risk of developing SSc increasing as the number of loops decreased. The presence of ANAs had a strong impact on prognosis [hazard ratio (HR) = 9.70], which was increased by the presence of ACA (HR = 3.94; P < 0.001). A weighted prognostic classification for the development of SSc was constructed using capillary number, giant loops and ANAs. The prognostic discrimination was satisfactory (Harrell's C-index = 0.86).
Conclusion: Our prognostic model is based on easy-to-obtain features (i.e. the number of capillaries, giant loops and ANAs) and could be used to facilitate clinical decision making in the screening phase, and may also have important implications for stratifying patients into risk groups for future clinical assessment.
Similar articles
-
Prognostic model based on nailfold capillaroscopy for identifying Raynaud's phenomenon patients at high risk for the development of a scleroderma spectrum disorder: PRINCE (prognostic index for nailfold capillaroscopic examination).Arthritis Rheum. 2008 Jul;58(7):2174-82. doi: 10.1002/art.23555. Arthritis Rheum. 2008. PMID: 18576359 Clinical Trial.
-
Capillaroscopy.Best Pract Res Clin Rheumatol. 2008 Dec;22(6):1093-108. doi: 10.1016/j.berh.2008.09.001. Best Pract Res Clin Rheumatol. 2008. PMID: 19041079 Review.
-
Computerized nailfold video capillaroscopy--a new tool for assessment of Raynaud's phenomenon.J Rheumatol. 2005 May;32(5):841-8. J Rheumatol. 2005. PMID: 15868619 Clinical Trial.
-
[Capillaroscopy of the nail fold in Raynaud's phenomenon and scleroderma].Med Clin (Barc). 1987 Oct 24;89(13):533-6. Med Clin (Barc). 1987. PMID: 3695683 Spanish. No abstract available.
-
[Capillaroscopy and vascular acrosyndromes].J Mal Vasc. 1999 Dec;24(5):357-62. J Mal Vasc. 1999. PMID: 10642647 Review. French.
Cited by
-
Aminaphtone Efficacy in Primary and Secondary Raynaud's Phenomenon: A Feasibility Study.Front Pharmacol. 2019 Apr 4;10:293. doi: 10.3389/fphar.2019.00293. eCollection 2019. Front Pharmacol. 2019. PMID: 31019461 Free PMC article.
-
The Relationship between TNF-a, IL-35, VEGF and Cutaneous Microvascular Dysfunction in Young Patients with Uncomplicated Type 1 Diabetes.Biomedicines. 2023 Oct 22;11(10):2857. doi: 10.3390/biomedicines11102857. Biomedicines. 2023. PMID: 37893230 Free PMC article.
-
Uniphasic Blanching of the Fingers, Abnormal Capillaroscopy in Nonsymptomatic Digits, and Autoantibodies: Expanding Options to Increase the Level of Suspicion of Connective Tissue Diseases beyond the Classification of Raynaud's Phenomenon.J Immunol Res. 2015;2015:371960. doi: 10.1155/2015/371960. Epub 2015 May 17. J Immunol Res. 2015. PMID: 26075287 Free PMC article.
-
[Capillaroscopy. An update].Z Rheumatol. 2013 Mar;72(2):145-50. doi: 10.1007/s00393-012-1069-6. Z Rheumatol. 2013. PMID: 23440376 Review. German.
-
Evidence-based management of Raynaud's phenomenon.Ther Adv Musculoskelet Dis. 2017 Dec;9(12):317-329. doi: 10.1177/1759720X17740074. Epub 2017 Nov 20. Ther Adv Musculoskelet Dis. 2017. PMID: 29201156 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical